Dogwood Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$895K Buy
746
+247
+49% +$252K 0.35% 38
2026
Q1
$459K Sell
499
-196
-28% -$199K 0.2% 51
2025
Q4
$747K Sell
695
-319
-31% -$305K 0.33% 45
2025
Q3
$774K Sell
1,014
-2
-0.2% -$1.49K 0.35% 57
2025
Q2
$790K Buy
1,016
+61
+6% +$47.4K 0.39% 54
2025
Q1
$789K Buy
955
+92
+11% +$76.6K 0.41% 44
2024
Q4
$667K Sell
863
-1,022
-54% -$846K 0.35% 51
2024
Q3
$1.67M Buy
1,885
+292
+18% +$263K 0.96% 29
2024
Q2
$1.44M Buy
1,593
+166
+12% +$133K 0.89% 29
2024
Q1
$1.11M Sell
1,427
-26
-2% -$18.5K 0.75% 29
2023
Q4
$847K Buy
+1,453
New +$848K 0.66% 32

Other funds holding LLY

Dogwood Wealth Management's LLY Position: Q2 2026 in Review

Dogwood Wealth Management increased its Eli Lilly (LLY) stake by 49% in Q2 2026, buying an estimated $252K and bringing the position to 746 shares worth $895K. The position accounts for 0.35% of the portfolio, ranked #38.

Dogwood Wealth Management first reported a position in LLY in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.67M in Q3 2024. 1,616 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Dogwood Wealth Management held 746 shares of Eli Lilly worth $895K as of Q2 2026.
  • Dogwood Wealth Management bought 247 Eli Lilly shares in Q2 2026, an estimated $252K.
  • Eli Lilly made up 0.35% of Dogwood Wealth Management's portfolio in Q2 2026, its #38 holding.
  • Dogwood Wealth Management first reported a position in Eli Lilly in Q4 2023 and has held it in 11 quarters since.
  • Dogwood Wealth Management's Eli Lilly position peaked at $1.67M in Q3 2024.
  • 1,616 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Dogwood Wealth Management's 13F filing for Q2 2026, filed 6 Jul 2026.